Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Rocio Moran, MD, is a Clinical Geneticist with the Cleveland Clinic's Genomic Medicine Institute. I am board-certified in pediatrics, medical genetics and board eligible in biochemical genetics.
One clinical focus is the identification, evaluation and diagnosis of patients with and at risk for cardiovascular disorders, specifically connective tissue disorders. I have established the first genetics program in Cleveland Clinic's Heart and Vascular Institute, an international leader in the treatment of cardiovascular disorders which includes genetic evaluations of patients with suspected heritable cardiovascular disease to provide personalized, disease-specific treatment recommendations.
The key to the success of this program is the appreciation of the impact a genetic diagnosis provides physicians, their patients and their families. Through the utilization of such services and my collaboration with Micheala Aldred, PhD in the Genomic Medicine Institute, we have identified a tremendous opportunity to advance the field of cardiovascular genetic medicine by studying populations of patients with common cardiovascular disease, focusing on Familial Thoracic Aortic Aneurysm and Dissection.
Another clinical focus is the evaluation of patients with suspected genetic syndromes. I am also interested in the diagnosis of patients with complex medical problems, children with birth defects and individuals with developmental disabilities in an effort to provide patients and their families a personalized medical treatment plan.
The diagnosis and management of patients with connective tissue disorders, developmental delays and suspected inherited disorders
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Moran's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.